At the news
? NEUTRALIMPACT 5/10 6-K filed Aug 4, 2026 at 06:14 ET
CCEP reported strong H1 2026 results with revenue of €10,724M (+4.4% reported, +6.1% FXN), comparable operating profit of €1,481M (+6.5% reported, +8.1% FXN), and comparable diluted EPS of €2.20 (+9.2% reported, +10.6% FXN). Full-year guidance was reaffirmed, including revenue growth of 3-4% and operating profit growth of 7%. The company also noted a €1B share buyback program with €593M completed as of July 31. The results are solid and in line with expectations, but the reaffirmation of guidance and the buyback provide no incremental catalyst for a bullish rating, making this a neutral event for a large-cap staple stock.
- H1 2026 revenue of €10,724M, up 4.4% reported and 6.1% on a comparable FX-neutral basis vs H1 2025.
- Comparable operating profit of €1,481M, up 6.5% reported and 8.1% on a comparable FX-neutral basis.
- Comparable diluted EPS of €2.20, up 9.2% reported and 10.6% on a comparable FX-neutral basis.
- Full-year 2026 guidance reaffirmed: revenue growth of 3-4%, operating profit growth of 7%, and comparable free cash flow of at least €1.7B.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access